Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
- 9 February 2021
- journal article
- letter
- Published by Elsevier BV in Journal of Infection
- Vol. 82 (6), 276-316
- https://doi.org/10.1016/j.jinf.2021.02.008
Abstract
No abstract availableKeywords
Funding Information
- American Diabetes Association (7–20-COVID-051)
- U.S. Department of Veterans Affairs (BX003725)
- National Institutes of Health (DK074970, DK107444)
This publication has 11 references indexed in Scilit:
- Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in GermanyClinical Research in Cardiology, 2021
- One- and 3-year outcomes of percutaneous bifurcation left main revascularization with modern drug-eluting stents: a systematic review and meta-analysisClinical Research in Cardiology, 2021
- Anticoagulation in Hospitalized Patients with Covid-19New England Journal of Medicine, 2020
- Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019Anesthesia & Analgesia, 2020
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19JAMA, 2020
- Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreBMJ, 2020
- Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort studyJournal of Infection, 2020
- Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health SystemJAMA, 2020
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019JAMA Network Open, 2020
- 2016 updated EULAR evidence-based recommendations for the management of goutAnnals Of The Rheumatic Diseases, 2016